| |||||||||

Industry (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Operating Income | 0 | 0 | 0 | 0 | 16.0B | |||
| Gross Profit | 36.0B | 38.7B | 40.4B | 46.1B | 48.1B | |||
| Total Revenues | 47.3B | 50.5B | 53.3B | 61.1B | 63.7B | |||
| Net Income | 8.51B | 10.4B | 11.1B | 10.6B | 12.9B | |||
| Gross Margin | 71.7% | 72.3% | 71.8% | 70.9% | 70.9% | |||
| Research and Development Expense | 5.34B | 6.46B | 7.12B | 7.68B | 7.58B | |||
| R&D/Sales Ratio | 11.3% | 12.8% | 13.4% | 12.6% | 11.9% | |||
| Research and Development - Consumer | 0 | 0 | 395M | 564M | 624M | |||
| Research and Development - Pharmaceutical | 0 | 0 | 4.96B | 5.26B | 5.09B | |||
| Research and Development - Medical Devices and Diagnostics | 0 | 0 | 1.77B | 1.85B | 1.86B | |||
| ||||||